7-43787996-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000265523.9(BLVRA):c.105G>A(p.Ala35=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00457 in 1,614,198 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 30 hom. )
Consequence
BLVRA
ENST00000265523.9 synonymous
ENST00000265523.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.599
Genes affected
BLVRA (HGNC:1062): (biliverdin reductase A) The protein encoded by this gene belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Mutations in this gene are associated with hyperbiliverdinemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 7-43787996-G-A is Benign according to our data. Variant chr7-43787996-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2055170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.599 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BLVRA | NM_000712.4 | c.105G>A | p.Ala35= | synonymous_variant | 3/8 | ENST00000265523.9 | NP_000703.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLVRA | ENST00000265523.9 | c.105G>A | p.Ala35= | synonymous_variant | 3/8 | 1 | NM_000712.4 | ENSP00000265523 | P1 | |
BLVRA | ENST00000402924.5 | c.105G>A | p.Ala35= | synonymous_variant | 4/9 | 2 | ENSP00000385757 | P1 | ||
BLVRA | ENST00000424330.1 | c.105G>A | p.Ala35= | synonymous_variant | 3/5 | 3 | ENSP00000412005 | |||
BLVRA | ENST00000453612.1 | n.129G>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00367 AC: 558AN: 152188Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
558
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00402 AC: 1012AN: 251468Hom.: 8 AF XY: 0.00398 AC XY: 541AN XY: 135908
GnomAD3 exomes
AF:
AC:
1012
AN:
251468
Hom.:
AF XY:
AC XY:
541
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00466 AC: 6811AN: 1461892Hom.: 30 Cov.: 33 AF XY: 0.00455 AC XY: 3312AN XY: 727248
GnomAD4 exome
AF:
AC:
6811
AN:
1461892
Hom.:
Cov.:
33
AF XY:
AC XY:
3312
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00366 AC: 558AN: 152306Hom.: 3 Cov.: 32 AF XY: 0.00387 AC XY: 288AN XY: 74464
GnomAD4 genome
AF:
AC:
558
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
288
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | BLVRA: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at